9.74MMarket Cap-316P/E (TTM)
1.190High1.060Low68.90KVolume1.090Open1.100Pre Close75.82KTurnover69.25%Turnover RatioLossP/E (Static)9.02MShares11.20052wk High0.64P/B107.46KFloat Cap0.83352wk Low--Dividend TTM99.50KShs Float595.826Historical High--Div YieldTTM11.81%Amplitude0.833Historical Low1.100Avg Price1Lot Size
Notable Labs Stock Forum
$Notable Labs(NTBL.US)$ $Notable Labs(NTBL.US)$
Presentation Details:
Date: Monday, May 13, 2024
NEWS
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
Notable Labs, presents the design for a Phase 2 trial with volasertib and decitabine in patients with relapsed/refractory AML at AACR 2024. The company aims to predict responders using their PPMP and develop a companion diagnostic test.
Poster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to p...
No comment yet